Peter G. Linde

Corporate Officer/Principal en Walden Biosciences, Inc. .

57 años

Health Technology

Finance

Health Services

Cargos activos de Peter G. Linde

Empresas	Cargo	Inicio	Fin
Walden Biosciences, Inc. Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA.	Corporate Officer/Principal	11/10/2022	-

Empresas	Cargo	Inicio	Fin
MORPHIC HOLDING, INC.	Director Técnico/Científico/I+D	17/03/2020	31/12/2021
FIBROGEN, INC.	Corporate Officer/Principal	-	-
ACCELERON PHARMA INC.	Corporate Officer/Principal	-	-

Massachusetts Institute of Technology

Undergraduate Degree

Internacional

Estados Unidos

Operativa

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1
Undergraduate Degree	1

Sectorial

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	2
MORPHIC HOLDING, INC.	Health Technology
FIBROGEN, INC.	Health Technology

Empresas privadas	2
Acceleron Pharma, Inc. Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ.	Health Technology
Walden Biosciences, Inc. Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA.	Health Services

Empresas privadas

Health Technology

Health Services